KRISTIE LAMOTTA: Open Payments
NPI 1356992606 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$497 in 26 payments from 14 companies in 2025. Trend: 2023 $660 · 2024 $579 · 2025 $497
Food & beverage: $497
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $169 |
| ABBVIE INC. | 3 | $62 |
| Amgen Inc. | 2 | $40 |
| Corcept Therapeutics | 2 | $36 |
| EMD Serono, Inc. | 1 | $26 |
| Organon LLC | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
Products named: Rybelsus, Ozempic, QULIPTA, OTEZLA, Korlym, Wegovy, NEXPLANON, VRAYLAR.
Industry payments across CO — which companies pay providers there.
